ABBV vs TTD: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and The Trade Desk, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-06.
AbbVie Inc. · Healthcare
$261.07
+1.2% upside to fair value
Grade C
High Quality
VS
The Trade Desk, Inc. · Communication Services
$18.51
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
TTD has more upside to fair value
(+45.0%).
TTD trades at a lower forward P/E
(20.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
TTD |
| Current Price |
$261.07 |
$18.51 |
| Fair Value Estimate |
$264.30 |
$26.84 |
| Upside to Fair Value |
+1.2%
|
+45.0%
|
| Market Cap |
$461.3B |
$8.7B |
| Forward P/E |
128.0x
|
20.3x
|
| EV / EBITDA |
31.0x
|
10.5x
|
| Price / Sales |
7.3x
|
2.9x
|
| Price / FCF |
22.1x
|
10.4x
|
| Revenue Growth YoY |
+12.4%
|
+11.8%
|
| Gross Margin |
70.7%
|
77.8%
|
| Operating Margin |
27.6%
|
20.3%
|
| Return on Equity |
68.0%
|
16.9%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.52%
|
9.62%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology and aesthetics. The company is transitioning from its historical Humira dominance, which has faced loss of exclusivity, toward high-growth assets like Skyrizi and Rinvoq that are driving robust revenue growth of 12.4% in the most recent quarter. Despite strong revenue growth and a dura…
The Trade Desk operates a leading demand-side platform in the advertising technology sector, specializing in programmatic ad buying with a strong focus on connected TV, retail media, audio, and international markets. The company benefits from a durable competitive moat driven by founder-led management with over 15 years of continuity, a differentiated open-internet infrastructure, and a dominant …
Accumulation Zones
| Metric |
ABBV |
TTD |
| Zone Low |
$198.23 |
$20.13 |
| Zone High |
$224.66 |
$22.81 |
| In Buy Zone? |
No
|
Yes
|